PERCEPTIVE ADVISORS LLC - 12 Oct 2021 Form 4 Insider Report for IsoPlexis Corp (ISO)

Role
10%+ Owner
Signature
/s/ Joseph Edelman - for Perceptive Advisors LLC, By: Joseph Edelman, its managing member
Issuer symbol
ISO
Transactions as of
12 Oct 2021
Net transactions value
+$12,750,000
Form type
4
Filing time
14 Oct 2021, 17:07:50 UTC
Previous filing
07 Oct 2021
Next filing
15 Oct 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISO Common Stock Conversion of derivative security +2,704,587 2,704,587 12 Oct 2021 By Perceptive Life Sciences Master Fund, Ltd. F1, F2, F5
transaction ISO Common Stock Conversion of derivative security +335,962 335,962 12 Oct 2021 By Perceptive Credit Holdings III, LP F1, F3, F6
transaction ISO Common Stock Conversion of derivative security +204,949 204,949 12 Oct 2021 By PCOF EQ AIV III, LP F1, F4, F7
transaction ISO Common Stock Purchase $12,750,000 +850,000 +31% $15.00* 3,554,587 12 Oct 2021 By Perceptive Life Sciences Master Fund, Ltd. F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISO Series D Redeemable Convertible Preferred Stock Conversion of derivative security $0 -325,014 -100% $0.000000* 0 12 Oct 2021 Common Stock 2,600,112 By Perceptive Life Sciences Master Fund, Ltd. F1, F2
transaction ISO Series D Redeemable Convertible Preferred Stock Conversion of derivative security $0 -40,373 -100% $0.000000* 0 12 Oct 2021 Common Stock 322,984 By Perceptive Credit Holdings III, LP F1, F3
transaction ISO Series D Redeemable Convertible Preferred Stock Conversion of derivative security $0 -24,629 -100% $0.000000* 0 12 Oct 2021 Common Stock 197,032 By PCOF EQ AIV III, LP F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of Series D Redeemable Convertible Preferred Stock, par value $0.001, of the Issuer (the "Preferred Stock") were convertible on a one-for-eight basis into shares of Common Stock of the Issuer at the option of the holder at any time and automatically converted upon the closing of the Issuer's initial public offering (the "IPO"). The Preferred Stock had no expiration date.
F2 The securities are directly held by Perceptive Life Sciences Master Fund, Ltd. ("Master Fund"). Perceptive Advisors LLC (the "Advisor") is the investment manager of the Master Fund. Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.
F3 The securities are directly held by Perceptive Credit Holdings III, LP ("PCH III"). Perceptive Credit Advisors, LLC ("Perceptive Credit") is the investment manager to PCH III. Joseph Edelman is the managing member of Perceptive Credit. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.
F4 The securities are directly held by PCOF EQ AIV III, LP ("PCOF"). Perceptive Credit is the investment manager to PCOF. Joseph Edelman is the managing member of Perceptive Credit. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.
F5 Includes 104,475 shares of Common Stock issued per dividends accrued to but not including October 12, 2021.
F6 Includes 12,978 shares of Common Stock issued per dividends accrued to but not including October 12, 2021.
F7 Includes 7,917 shares of Common Stock issued per dividends accrued to but not including October 12, 2021.